These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37964286)

  • 1. A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms.
    Perri M; Khorasheh T; Poon DE; Kaminski N; LeBlanc S; Mizon L; Smoke A; Strike C; Leece P
    Harm Reduct J; 2023 Nov; 20(1):169. PubMed ID: 37964286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.
    Leece P; Khorasheh T; Paul N; Keller-Olaman S; Massarella S; Caldwell J; Parkinson M; Strike C; Taha S; Penney G; Henderson R; Manson H
    BMJ Open; 2019 Sep; 9(9):e028583. PubMed ID: 31515417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaving the Hospital Against Medical Advice Among People Who Use Illicit Drugs: A Systematic Review.
    Ti L; Ti L
    Am J Public Health; 2015 Dec; 105(12):e53-9. PubMed ID: 26469651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.
    Olding M; Boyd J; Kerr T; Fowler A; McNeil R
    Int J Drug Policy; 2023 Jan; 111():103929. PubMed ID: 36529032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research led by people who use drugs: centering the expertise of lived experience.
    Salazar ZR; Vincent L; Figgatt MC; Gilbert MK; Dasgupta N
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):70. PubMed ID: 34544478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.
    Safi F; Rioux W; Rider N; Fornssler B; Jones S; Ghosh SM
    Harm Reduct J; 2023 May; 20(1):64. PubMed ID: 37158926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol.
    Salvalaggio G; Ferguson L; Brooks HL; Campbell S; Gladue V; Hyshka E; Lam L; Morris H; Nixon L; Springett J
    Syst Rev; 2022 Apr; 11(1):66. PubMed ID: 35418306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G; Strike C
    Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.